BamSEC and AlphaSense Join Forces
Learn More

Peak Bio Inc.

OTC: PKBO    
Share price (11/14/24): $0.02    
Market cap (11/14/24): $520 thousand
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 5 pages Non-Qualified Stock Option Agreement for Employee and Consultants Under the Peak Bio, Inc. 2022 Long Term Incentive Plan
12/34/56
EX-10.1
from 8-K 5 pages Non-Qualified Stock Option Agreement for Non-Employee Directors Under the Peak Bio, Inc. 2022 Long Term Incentive Plan
12/34/56
EX-10.1
from 8-K 9 pages Separation and General Release Agreement 1
12/34/56
EX-10.1
from 8-K 17 pages Peak Bio, Inc. Secured Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 15 pages Peak Bio, Inc. Secured Convertible Promissory Note
12/34/56
EX-10.2
from 8-K 9 pages Voting and Support Agreement
12/34/56
EX-10.1
from 8-K 9 pages Voting and Support Agreement
12/34/56
EX-10.2
from 8-K 4 pages Security Agreement
12/34/56
EX-10.1
from 8-K 4 pages Senior Secured Promissory Note Dated January 23, 2024
12/34/56
EX-10.2
from 8-K 5 pages Peak Bio, Inc. Unsecured Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 15 pages Peak Bio, Inc. Convertible Note Subscription Agreement Agreement
12/34/56
EX-10.1
from 8-K 5 pages Second Amendment to Common Stock Purchase Agreement Between Peak Bio, Inc. and White Lion Capital LLC
12/34/56
EX-10.5
from 8-K 12 pages Purchase Warrant Issued To: Paulson Investment Company, LLC Exercisable to Purchase 194,670 Shares of Common Stock of Peak Bio, Inc. Issue Date: April 28, 2023 Expiration Date: April 28, 2028
12/34/56
EX-10.4
from 8-K 20 pages Subscription Agreement
12/34/56
EX-10.3
from 8-K 10 pages Warrant to Purchase Shares of Common Stock as Herein Described April 28, 2023 Warrant to Purchase Common Stock of Peak Bio, Inc
12/34/56
EX-10.2
from 8-K 5 pages Unsecured Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 19 pages Subscription Agreement
12/34/56
EX-10.1
from 8-K 3 pages Second Amendment to Lock-Up Agreement
12/34/56
EX-10.1
from 8-K 1 page April 5, 2023 Dr. Hoyoung Huh Re: Debt Conversion in Future Qualified Financings Dr. Huh: Very Truly Yours, /S/ Stephen Lamond Stephen Lamond Interim CEO and COO Agreed and Accepted: /S/ Hoyoung Huh Hoyoung Huh, M.D., PH.D
12/34/56
EX-10.1
from 8-K 5 pages Amendment to Common Stock Purchase Agreement Between Peak Bio, Inc. and White Lion Capital LLC
12/34/56